222 related articles for article (PubMed ID: 18708119)
1. Human microvascular endothelial cells are sensitive to IGF-I but resistant to insulin at the receptor level.
Johansson GS; Chisalita SI; Arnqvist HJ
Mol Cell Endocrinol; 2008 Dec; 296(1-2):58-63. PubMed ID: 18708119
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor I receptors are more abundant than insulin receptors in human micro- and macrovascular endothelial cells.
Chisalita SI; Arnqvist HJ
Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E896-901. PubMed ID: 14722023
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of receptors for IGF-I and insulin; evidence for hybrid insulin/IGF-I receptor in human coronary artery endothelial cells.
Chisalita SI; Nitert MD; Arnqvist HJ
Growth Horm IGF Res; 2006 Aug; 16(4):258-66. PubMed ID: 16914341
[TBL] [Abstract][Full Text] [Related]
4. IGF-I/insulin hybrid receptors in human endothelial cells.
Nitert MD; Chisalita SI; Olsson K; Bornfeldt KE; Arnqvist HJ
Mol Cell Endocrinol; 2005 Jan; 229(1-2):31-7. PubMed ID: 15607526
[TBL] [Abstract][Full Text] [Related]
5. Human aortic smooth muscle cells are insulin resistant at the receptor level but sensitive to IGF1 and IGF2.
Chisalita SI; Johansson GS; Liefvendahl E; Bäck K; Arnqvist HJ
J Mol Endocrinol; 2009 Dec; 43(6):231-9. PubMed ID: 19589910
[TBL] [Abstract][Full Text] [Related]
6. Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells.
Johansson GS; Arnqvist HJ
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1124-30. PubMed ID: 16803852
[TBL] [Abstract][Full Text] [Related]
7. Insulin and IGF1 receptors in human cardiac microvascular endothelial cells: metabolic, mitogenic and anti-inflammatory effects.
Bäck K; Islam R; Johansson GS; Chisalita SI; Arnqvist HJ
J Endocrinol; 2012 Oct; 215(1):89-96. PubMed ID: 22825921
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of IGF-I and insulin receptor isoforms in HPV positive and negative human cervical cancer cell lines.
Serrano ML; Sánchez-Gómez M; Bravo MM; Yakar S; LeRoith D
Horm Metab Res; 2008 Oct; 40(10):661-7. PubMed ID: 18711691
[TBL] [Abstract][Full Text] [Related]
9. In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A.
Sciacca L; Mineo R; Pandini G; Murabito A; Vigneri R; Belfiore A
Oncogene; 2002 Nov; 21(54):8240-50. PubMed ID: 12447687
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of IGF-I, IGF-II and insulin in human preadipocytes and adipocytes--role of insulin and IGF-I receptors.
Bäck K; Brännmark C; Strålfors P; Arnqvist HJ
Mol Cell Endocrinol; 2011 Jun; 339(1-2):130-5. PubMed ID: 21524684
[TBL] [Abstract][Full Text] [Related]
11. Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.
Shukla A; Grisouard J; Ehemann V; Hermani A; Enzmann H; Mayer D
Endocr Relat Cancer; 2009 Jun; 16(2):429-41. PubMed ID: 19153208
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of insulin and insulin-like growth factor-1 hybrid receptors and decreased glycosylation of the insulin receptor alpha- and beta-subunits in scrapie-infected neuroblastoma N2a cells.
Nielsen D; Gyllberg H; Ostlund P; Bergman T; Bedecs K
Biochem J; 2004 Jun; 380(Pt 2):571-9. PubMed ID: 15025560
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of signaling pathways for insulin and insulin-like growth factor I.
Lopaczynski W
Acta Biochim Pol; 1999; 46(1):51-60. PubMed ID: 10453981
[TBL] [Abstract][Full Text] [Related]
14. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
[TBL] [Abstract][Full Text] [Related]
15. Changes in insulin and IGF-I receptor expression during differentiation of human preadipocytes.
Bäck K; Arnqvist HJ
Growth Horm IGF Res; 2009 Apr; 19(2):101-11. PubMed ID: 18693051
[TBL] [Abstract][Full Text] [Related]
16. Effects of hyperglycemia on the differential expression of insulin and insulin-like growth factor-I receptors in human normal peritoneal and adhesion fibroblasts.
Rizk NN; Saed GM; Diamond MP
Fertil Steril; 2006 Oct; 86(4 Suppl):1217-22. PubMed ID: 16962112
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.
Law JH; Habibi G; Hu K; Masoudi H; Wang MY; Stratford AL; Park E; Gee JM; Finlay P; Jones HE; Nicholson RI; Carboni J; Gottardis M; Pollak M; Dunn SE
Cancer Res; 2008 Dec; 68(24):10238-46. PubMed ID: 19074892
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
Zhang H; Pelzer AM; Kiang DT; Yee D
Cancer Res; 2007 Jan; 67(1):391-7. PubMed ID: 17210722
[TBL] [Abstract][Full Text] [Related]
19. Cys 786 and Cys 776 in the posttranslational processing of the insulin and IGF-I receptors.
Maggi D; Cordera R
Biochem Biophys Res Commun; 2001 Jan; 280(3):836-41. PubMed ID: 11162597
[TBL] [Abstract][Full Text] [Related]
20. The role of IGF-system in vascular insulin resistance.
Arnqvist HJ
Horm Metab Res; 2008 Sep; 40(9):588-92. PubMed ID: 18792869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
